|
UGGT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.767300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.219300E-03 |
| Normal-vs-Stage2 |
1.190450E-01 |
| Normal-vs-Stage3 |
2.36869999999945E-05 |
| Normal-vs-Stage4 |
3.98759999999942E-05 |
| Stage1-vs-Stage2 |
5.233400E-01 |
| Stage1-vs-Stage3 |
4.478000E-02 |
| Stage1-vs-Stage4 |
3.078100E-02 |
| Stage2-vs-Stage3 |
7.092200E-02 |
| Stage2-vs-Stage4 |
3.060300E-02 |
| Stage3-vs-Stage4 |
4.963400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.570930E-04 |
| Normal-vs-AfricanAmerican |
8.469700E-02 |
| Normal-vs-Asian |
3.839100E-04 |
| Caucasian-vs-AfricanAmerican |
4.271400E-01 |
| Caucasian-vs-Asian |
4.912600E-01 |
| AfricanAmerican-vs-Asian |
1.829550E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.024300E-04 |
| Normal-vs-Female |
1.504530E-03 |
| Male-vs-Female |
2.191200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.282320E-02 |
| Normal-vs-Age(41-60Yrs) |
1.552640E-04 |
| Normal-vs-Age(61-80Yrs) |
6.599000E-04 |
| Normal-vs-Age(81-100Yrs) |
4.933600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.197560E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.578000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.495600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.555600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.623200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.045600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.050200E-02 |
| Classical-VS-Follicular |
4.215200E-01 |
| Classical-VS-Other |
1.106360E-01 |
| Classical-VS-Normal |
8.826600E-04 |
| Tall-VS-Follicular |
7.837000E-03 |
| Tall-VS-Other |
6.582400E-01 |
| Tall-VS-Normal |
4.10029999999839E-05 |
| Follicular-VS-Other |
1.439840E-01 |
| Follicular-VS-Normal |
7.025600E-02 |
| Other-VS-Normal |
6.522000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.378200E-03 |
| Normal-vs-N1 |
1.67855999999578E-05 |
| N0-vs-N1 |
2.180200E-02 |
|
|
